Future studies exploring the molecular mechanisms underlying the estrogen regulation of Del-1 expression in these cellular contexts would provide valuable insights into the pathogenesis of postmenopausal osteoporosis. Here, EDIL3 is linked to postmenopausal osteoporosis.